FIA
ZSAN

FNY Investment Advisers’s Zosano Pharma Corporation ZSAN Stock Holding History

FNY Investment Advisers’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,857
Closed -$152K – 928
2019
Q4 		$152K Sell
2,857
-1,429
-33% -$88.2K 0.05% 295
2019
Q3 		$234K Buy
+4,286
New +$384K 0.07% 158
2018
Q3 		– Sell
-1,381
Closed -$197K – 1395
2018
Q2 		$197K Buy
+1,381
New +$208K 0.08% 156

Other funds holding ZSAN

ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FNY Investment Advisers's ZSAN Position: Q1 2020 in Review

FNY Investment Advisers sold out of Zosano Pharma Corporation (ZSAN) in Q1 2020, closing a stake of 2,857 shares — an estimated $152K sold.

FNY Investment Advisers first reported a position in ZSAN in Q2 2018 and held it in 3 quarters. The position peaked at $234K in Q3 2019. 29 funds tracked by Wall St. Rank hold ZSAN as of Q1 2020.

  • FNY Investment Advisers reported no remaining Zosano Pharma Corporation position as of Q1 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 2,857 Zosano Pharma Corporation shares in Q1 2020, an estimated $152K.
  • FNY Investment Advisers first reported a position in Zosano Pharma Corporation in Q2 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Zosano Pharma Corporation position peaked at $234K in Q3 2019.
  • 29 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2020.

Based on FNY Investment Advisers's 13F filing for Q1 2020, filed 9 Apr 2020.